Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OSELTAMIVIR vs OXALIPLATIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OSELTAMIVIR vs OXALIPLATIN: Safety Overview

Metric OSELTAMIVIR OXALIPLATIN
Total FAERS Reports 11,686 56,406
Deaths Reported 1,045 6,501
Death Rate 8.9% 11.5%
Hospitalizations 2,284 21,980
Average Patient Age 42.4 yrs 61.5 yrs
% Female Patients 54.2% 42.1%
FDA Approval Date Aug 3, 2016 Apr 28, 2011
Manufacturer Proficient Rx LP Camber Pharmaceuticals, Inc.
Route ORAL INTRAVENOUS
Marketing Status Prescription Discontinued